2013
- Kilarski WW, Güç E, Teo JC, Oliver SR, Lund AW, and Swartz MA. Intravital immunofluorescence for visualizing the microcirculatory and immune microenvironments in the mouse ear dermis. PLoS One. 2013;8(2):e57135. DOI:10.1371/journal.pone.0057135 | PubMed ID:23451163 | HubMed [Paper1]
2012
- Lund AW, Duraes FV, Hirosue S, Raghavan VR, Nembrini C, Thomas SN, Issa A, Hugues S, and Swartz MA. VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics. Cell Rep. 2012 Mar 29;1(3):191-9. DOI:10.1016/j.celrep.2012.01.005 | PubMed ID:22832193 | HubMed [Paper2]
- Swartz MA and Lund AW. Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity. Nat Rev Cancer. 2012 Feb 24;12(3):210-9. DOI:10.1038/nrc3186 | PubMed ID:22362216 | HubMed [Paper3]
All Medline abstracts: PubMed | HubMed
2010
- Solorio L, Zwolinski C, Lund AW, Farrell MJ, and Stegemann JP. Gelatin microspheres crosslinked with genipin for local delivery of growth factors. J Tissue Eng Regen Med. 2010 Oct;4(7):514-23. DOI:10.1002/term.267 | PubMed ID:20872738 | HubMed [Paper4]
- Bilgin CC, Lund AW, Can A, Plopper GE, and Yener B. Quantification of three-dimensional cell-mediated collagen remodeling using graph theory. PLoS One. 2010 Sep 30;5(9). DOI:10.1371/journal.pone.0012783 | PubMed ID:20927339 | HubMed [Paper5]
- Lund AW and Swartz MA. Role of lymphatic vessels in tumor immunity: passive conduits or active participants?. J Mammary Gland Biol Neoplasia. 2010 Sep;15(3):341-52. DOI:10.1007/s10911-010-9193-x | PubMed ID:20835756 | HubMed [Paper6]
All Medline abstracts: PubMed | HubMed
2009
- Lund AW, Yener B, Stegemann JP, and Plopper GE. The natural and engineered 3D microenvironment as a regulatory cue during stem cell fate determination. Tissue Eng Part B Rev. 2009 Sep;15(3):371-80. DOI:10.1089/ten.teb.2009.0270 | PubMed ID:19505193 | HubMed [Paper7]
- Lund AW, Stegemann JP, and Plopper GE. Inhibition of ERK promotes collagen gel compaction and fibrillogenesis to amplify the osteogenesis of human mesenchymal stem cells in three-dimensional collagen I culture. Stem Cells Dev. 2009 Mar;18(2):331-41. DOI:10.1089/scd.2008.0075 | PubMed ID:18491946 | HubMed [Paper8]
- Lund AW, Bilgin CC, Hasan MA, McKeen LM, Stegemann JP, Yener B, Zaki MJ, and Plopper GE. Quantification of spatial parameters in 3D cellular constructs using graph theory. J Biomed Biotechnol. 2009;2009:928286. DOI:10.1155/2009/928286 | PubMed ID:19920859 | HubMed [Paper9]
- Lund AW, Stegemann JP, and Plopper GE. Mesenchymal Stem Cells Sense Three Dimensional Type I Collagen through Discoidin Domain Receptor 1. Open Stem Cell J. 2009;1:40-53. DOI:10.2174/1876893800901010040 | PubMed ID:20589230 | HubMed [Paper10]
All Medline abstracts: PubMed | HubMed
2008
- Lund AW, Bush JA, Plopper GE, and Stegemann JP. Osteogenic differentiation of mesenchymal stem cells in defined protein beads. J Biomed Mater Res B Appl Biomater. 2008 Oct;87(1):213-21. DOI:10.1002/jbm.b.31098 | PubMed ID:18431753 | HubMed [Paper11]
2005
- Batorsky A, Liao J, Lund AW, Plopper GE, and Stegemann JP. Encapsulation of adult human mesenchymal stem cells within collagen-agarose microenvironments. Biotechnol Bioeng. 2005 Nov 20;92(4):492-500. DOI:10.1002/bit.20614 | PubMed ID:16080186 | HubMed [Paper12]
|